This week, we’re reading about the state of vaccine makers and smaller PBMs’ views on the federal reforms to regulation of PBM contract terms. We’re also reading about several developments in the states, including PBM regulations in Rhode Island, state insurance coverage of GLP-1s in Delaware, and the heavy flu season’s impact on Wichita pharmacies.
- New York Times: Vaccine Makers Curtail Research and Cut Jobs
- CNN: FDA reverses course and will review Moderna's mRNA flu shot, company says
- Managed Healthcare Executive: Upstart PBMs shrug off impact of reform law on their companies
- Contagion: Looking to Improve Healthcare Access, Pfizer Launches Digital Platform
- Rhode Island Current: Auditors showed up unannounced at 3 independent pharmacies. This RI law was ready for them.
- Wisconsin Public Radio: How new TrumpRx program could affect Wisconsin pharmacies and patients
- Delaware Business Now: Delaware weighs cutting GLP-1 coverage on state plan
- KWCH: Worst flu season in decades closes Kansas schools, floods Wichita pharmacies
- Greenfield Recorder: 'A vital health resource' returns: Baker Pharmacy in Shelburne Falls to reopen Feb. 23
NCPA
